Sivakumar Reddy, M.D.
Investigator
Sivakumar Reddy, MD, is a hematologist-oncologist at Sutter Roseville Medical Center, a researcher at the Sutter Institute for Medical Research, and a member of the Sutter Medical Group. He is board certified in internal medicine, hematology, and medical oncology.
Dr. Reddy investigates novel therapies for hematologic malignancies and solid tumor cancers. He participates in clinical trials in these areas and has authored numerous publications in hematology/oncology. He is a treating investigator for Southwest Oncology Group and National Cancer Institute-sponsored oncology group clinical trials.
Dr. Reddy obtained his MD from Jawaharlal Institute of Postgraduate Medical Education & Research in Puducherry, India. He completed residency training in internal medicine at Coney Island Hospital in Brooklyn, New York and fellowships in hematology and medical oncology at Coney Island Hospital and Lenox Hill Hospital in New York, NY, respectively.
Clinical trials
Beamion LUNG-3: A Randomized, Controlled, Multi-center Trial Evaluating Zongertinib as an Adjuvant Monotherapy Compared With Standard of Care in Patients With Early-stage, Resectable Non-small Cell Lung Cancer (Stage II-IIIB) Harboring Tyrosine Kinase Domain Activating HER2 Mutations
Status: Open to Enrollment
- Clinical trial
Adjuvant Monotherapy vs. Standard of Care Early-stage, Resectable Non-small Cell Lung Cancer
Beamion LUNG-3: A Randomized, Controlled, Multi-center Trial Evaluating Zongertinib as an Adjuvant Monotherapy Compared With Standard of Care in Patients With Early-stage, Resectable Non-small Cell Lung Cancer (Stage II-IIIB) Harboring Tyrosine Kinase Domain Activating HER2 Mutations
Status: Coming Soon
An Interventional Phase 3, Double-blind, Randomized Study to Evaluate Efficacy and Safety of PF-08634404 in Combination with Chemotherapy Versus Pembrolizumab in Combination with Chemotherapy in Adult Participants with Locally Advanced or Metastatic Non-small Cell Lung Cancer
Status: Open to Enrollment